UBI集團訊息

View More
UBI集團訊息
18042019
United BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicine

United BioPharma’s novel antibody UB-421 suppresses HIV without eliciting resistance

UBI group

王長怡博士

愛滋病治療單株抗體UB-421
more
United BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicine
View More
UBI集團訊息
18042019
聯生藥治療愛滋病抗體新藥 UB-421 臨床 II 期試驗結果榮獲刊登於新英格蘭醫學期刊

「Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption」榮獲刊登於最新一期的NEJM。

UBI group

王長怡博士

愛滋病治療單株抗體UB-421
more
聯生藥治療愛滋病抗體新藥 UB-421 臨床 II 期試驗結果榮獲刊登於新英格蘭醫學期刊
View More
UBI集團訊息
10102018
Is an Alzheimer’s Vaccine Possible? This Woman Thinks So

UB-311 could be a game-changer in a space severely lacking one.

UBI group

阿茲海默症治療型疫苗UB-311
more
Is an Alzheimer’s Vaccine Possible? This Woman Thinks So
View More
UBI集團訊息
10102018
Mei Mei Hu | Democratizing Brain Health | Global Summit 2018 | Singularity University

Mei Mei Hu, CEO, United Neuroscience

UBI group
more
Mei Mei Hu | Democratizing Brain Health | Global Summit 2018 | Singularity University
View More
UBI集團訊息
25092018
Meimei Hu, CEO of United Neuroscience, is to participate in Fortune Most Powerful Women Summit 2018

Meimei Hu, CEO of United Neuroscience, is to participate in Fortune Most Powerful Women Summit 2018

UBI group
more
Meimei Hu, CEO of United Neuroscience, is to participate in Fortune Most Powerful Women Summit 2018
View More
UBI集團訊息
05092018
聯亞集團與長庚大學建教合作_作育英才提升臺灣生技產業競爭力

聯亞集團與長庚大學建教合作-107學年度暑期實習成果競賽於107年9月3日圓滿順利完成，實習生們皆有非常優異的傑出表現！

UBI group
more
聯亞集團與長庚大學建教合作_作育英才提升臺灣生技產業競爭力
View More
UBI集團訊息
22082018
聯生藥加碼台灣5年內將投資數十億擴產

聯生藥預計8/29停止興櫃買賣，轉往海外掛牌！董事王長怡表示，根留台灣信念不變，將持續投資台灣

UBI group
more
聯生藥加碼台灣5年內將投資數十億擴產
View More
UBI集團訊息
14082018
聯合生物製藥為長期發展策略，董事會決議終止櫃檯買賣(問答集更新&新聞稿)

更新問答集&新聞稿

UBI group
more
聯合生物製藥為長期發展策略，董事會決議終止櫃檯買賣(問答集更新&新聞稿)
View More
UBI集團訊息
20072018
聯生藥治療氣喘和過敏單株抗體UB-221 榮獲2018臺北生技獎新創技術銅獎

開發中針對治療過敏症的創新抗IgE單株抗體UB-221研發成果備受肯定，榮獲2018年台北生技獎新創技術獎之「銅獎」。

UBI group

創新型IgE單株抗體UB-221
more
聯生藥治療氣喘和過敏單株抗體UB-221 榮獲2018臺北生技獎新創技術銅獎
View More
UBI集團訊息
12062018
聯生藥抗IgE 抗體新藥UB-221 將進入人體臨床一期試驗

向台灣食品藥物管理署提交創新抗IgE 抗體新藥UB-221 之人體臨床一期試驗申請。

UBI group

創新型IgE單株抗體UB-221
more
聯生藥抗IgE 抗體新藥UB-221 將進入人體臨床一期試驗
View More
UBI集團訊息
01062018
聯生藥進軍陸抗體藥市場

為拓展中國龐大且剛起步的單株抗體藥物市場，並作為前進國際的第一步，聯生藥分別於上海與揚州成立兩家子公司

UBI group

王長怡博士
more
聯生藥進軍陸抗體藥市場
View More
UBI集團訊息
28042018
United Neuroscience to Present at the Vatican’s Pontifical Council for Culture and the Cura Foundation’s Fourth International ‘Unite To Cure’ Conference in Vatican City

United Neuroscience to Present at the Vatican’s Pontifical Council for Culture and the Cura Foundation’s Fourth International ‘Unite To Cure’ Conference in Vatican City

UBI group
more
United Neuroscience to Present at the Vatican’s Pontifical Council for Culture and the Cura Foundation’s Fourth International ‘Unite To Cure’ Conference in Vatican City